Author

O. Alcazar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

P. Buchwald· 3 shared D. Bojadzic· 2 shared B.-J. M. Webb-Robertson· 1 shared E. S. Nakayasu· 1 shared G. Ren· 1 shared J. Chen· 1 shared M. H. Abdulreda· 1 shared M. Ogihara· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

P. Buchwald

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Composite Biomarker Signature of Type 1 Diabetes Risk Identified via Augmentation of Parallel Multi-Omics Data from a Small Cohort

O. Alcazar, S.-T. Chuang, G. Ren, M. Ogihara, B.-J. M. Webb-Robertson, E. S. Nakayasu, P. Buchwald, M. H. Abdulreda

The paper validates 12 biomarkers from a small T1D cohort using data augmentation, identifying 7 significantly altered markers linked to T1D risk.

bioRxiv · Feb 9, 2024 · PreprintBiochemistry

Small-Molecule In Vitro Inhibitors of the Coronavirus Spike - ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2

D. Bojadzic, O. Alcazar, J. Chen, P. Buchwald

The paper identifies small-molecule inhibitors of the SARS-CoV-2 spike-ACE2 interaction, showing they block viral entry with low micromolar activity.

bioRxiv · Oct 22, 2020Pharmacology & Toxicology

Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike - ACE2 Protein-Protein Interaction - A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19

D. Bojadzic, O. Alcazar, P. Buchwald

This paper identifies methylene blue as an inhibitor of the SARS-CoV-2 spike-ACE2 interaction, suggesting it may contribute to its antiviral activity against COVID-19.

bioRxiv · Aug 29, 2020Pharmacology & Toxicology